Thyroid cancer risk in WTC responders
世贸中心响应者的甲状腺癌风险
基本信息
- 批准号:9264863
- 负责人:
- 金额:$ 50万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-09-01 至 2019-08-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Summary
An excess incidence of thyroid cancer has been identified among World Trade Center (WTC)
rescue and recovery workers included in the WTC Health Program (WTCHP) at Mount Sinai in New
York. An excess has also been reported among participants of two separate WTC-exposed cohorts.
It is unclear whether the excess is associated with WTC-related exposures or represents an artifact
due to increased surveillance. Current understanding of the etiology and pathogenesis of thyroid
cancer is limited, and an association between this cancer and WTC-related exposures would add
significant information for the health of WTC responders and beyond. Conversely, the finding that
excess risk among WTCHP participants is not attributable to WTC related exposures, but to over-
diagnosis because of enhanced surveillance, perhaps related to the increased number of chest
imaging due to respiratory problems in this population, would represent an important message to
WTCHP members. The objectives of this project are to elucidate the reasons for the increased
incidence of thyroid cancer among WTCHP participants and to explore the behavior of these cancers.
Specifically, the project will investigate clinical and epidemiological characteristics of thyroid
cancer in WTC responders and compare them to those of matched non-WTC thyroid cancers: tumor
size, nodal involvement, local and distant metastatic spread, previous history of chest imaging,
frequency of medical visits, diagnosis because of symptoms vs. asymptomatic finding during medical
surveillance will be compared between the two groups of patients. The prevalence of tyroid cancer
risk factors will also be compared between the two groups.
The second task of this project is to identify in thyroid tissue samples markers of malignancy
that were found to be able to accurately discriminate between benign and malignant thyroid follicular
carcinoma. This approach will identify and eliminate false positives for the diagnosis of malignancy.
Although there is always an area of uncertainty when scoring a thyroid cancer as malignant, we
hypothesize that a false diagnosis of malignancy is more likely to occur among WTC responders than
in non WTC thyroid cancers, because of increased surveillance and a more conservative approach
towards this population.
Upon completion of this study, if the increased incidence appears to be real, the result could
have important implications in terms of surveillance and care; if the effects of excess surveillance are
proven, that would argue for a decrease in the intensity of screening. In both cases, the project will
have important implications on the surveillance and clinical management of thyroid cancer, a frequent
cancer among WTCHP members.
总结
世界贸易中心(WTC)的甲状腺癌发病率过高
救援和恢复工作人员包括在世贸中心卫生计划(WTCHP)在西奈山在新
约克。在两个单独的WTC暴露队列的参与者中也报告了过量。
目前还不清楚过量是否与WTC相关的暴露有关,或者代表人为因素
由于加强了监控。甲状腺疾病病因病机的研究现状
癌症是有限的,这种癌症和WTC相关暴露之间的关联将增加
为WTC响应者和其他人的健康提供重要信息。相反,
WTCHP参与者的过度风险不是归因于WTC相关暴露,而是过度-
由于加强监测而确诊,可能与胸部数量增加有关
成像由于呼吸问题,在这一人群中,将代表一个重要的信息,
WTCHP成员。本项目的目标是阐明增加的原因,
WTCHP参与者中甲状腺癌的发病率,并探讨这些癌症的行为。
具体而言,该项目将调查甲状腺疾病的临床和流行病学特征,
WTC应答者的甲状腺癌,并将其与匹配的非WTC甲状腺癌进行比较:肿瘤
大小、淋巴结受累、局部和远处转移扩散、既往胸部影像学史,
就诊频率,因症状而诊断与医疗期间无症状发现
将对两组患者的监测进行比较。甲状腺癌的患病率
并比较两组的危险因素。
该项目的第二项任务是在甲状腺组织样本中识别恶性肿瘤的标志物
发现能够准确区分良性和恶性甲状腺滤泡
carcinoma.这种方法将识别和消除恶性肿瘤诊断的假阳性。
虽然在将甲状腺癌评分为恶性时总是存在不确定性,但我们
假设恶性肿瘤的误诊更可能发生在WTC应答者中,
在非WTC甲状腺癌中,由于增加了监测和更保守的方法,
对这个人口。
完成本研究后,如果发生率增加似乎是真实的,则结果可能
在监测和护理方面具有重要意义;如果过度监测的影响
这一点已经得到证实,这将为降低筛查强度提供依据。在这两种情况下,该项目将
对甲状腺癌的监测和临床管理具有重要意义,
WTCHP成员中的癌症。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GREGORY Joseph RIGGINS其他文献
GREGORY Joseph RIGGINS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GREGORY Joseph RIGGINS', 18)}}的其他基金
Optimizing demethylating therapy for IDH1 Mutant Malignant Gliomas
优化 IDH1 突变恶性胶质瘤的去甲基化治疗
- 批准号:
10329949 - 财政年份:2015
- 资助金额:
$ 50万 - 项目类别:
Optimizing demethylating therapy for IDH1 Mutant Malignant Gliomas
优化 IDH1 突变恶性胶质瘤的去甲基化治疗
- 批准号:
9067335 - 财政年份:2015
- 资助金额:
$ 50万 - 项目类别:
Optimizing demethylating therapy for IDH1 Mutant Malignant Gliomas
优化 IDH1 突变恶性胶质瘤的去甲基化治疗
- 批准号:
9256449 - 财政年份:2015
- 资助金额:
$ 50万 - 项目类别:
Optimizing demethylating therapy for IDH1 Mutant Malignant Gliomas
优化 IDH1 突变恶性胶质瘤的去甲基化治疗
- 批准号:
10545735 - 财政年份:2015
- 资助金额:
$ 50万 - 项目类别:
Optimizing demethylating therapy for IDH1 Mutant Malignant Gliomas
优化 IDH1 突变恶性胶质瘤的去甲基化治疗
- 批准号:
10094197 - 财政年份:2015
- 资助金额:
$ 50万 - 项目类别:
Optimizing demethylating therapy for IDH1 Mutant Malignant Gliomas
优化 IDH1 突变恶性胶质瘤的去甲基化治疗
- 批准号:
9884278 - 财政年份:2015
- 资助金额:
$ 50万 - 项目类别:
Preoperative and follow-up tests for thyroid tumors
甲状腺肿瘤的术前和随访检查
- 批准号:
7877304 - 财政年份:2009
- 资助金额:
$ 50万 - 项目类别:
Preoperative and follow-up tests for thyroid tumors
甲状腺肿瘤的术前和随访检查
- 批准号:
7879993 - 财政年份:2009
- 资助金额:
$ 50万 - 项目类别:
Glioblastoma Genome Project to Locate Molecular Targets
胶质母细胞瘤基因组计划定位分子靶点
- 批准号:
7273719 - 财政年份:2006
- 资助金额:
$ 50万 - 项目类别:
Glioblastoma Genome Project to Locate Molecular Targets
胶质母细胞瘤基因组计划定位分子靶点
- 批准号:
7098137 - 财政年份:2006
- 资助金额:
$ 50万 - 项目类别:
相似国自然基金
5'-tRF-GlyGCC通过SRSF1调控RNA可变剪切促三阴性乳腺癌作用机制及干预策略
- 批准号:82372743
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
脊髓电刺激活化Na(V)1.1阳性GABA神经元持续缓解癌痛
- 批准号:82371223
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
丁酸梭菌代谢物(如丁酸、苯乳酸)通过MYC-TYMS信号轴影响结直肠癌化疗敏感性的效应及其机制研究
- 批准号:82373139
- 批准年份:2023
- 资助金额:48.00 万元
- 项目类别:面上项目
均相液相生物芯片检测系统的构建及其在癌症早期诊断上的应用
- 批准号:82372089
- 批准年份:2023
- 资助金额:48.00 万元
- 项目类别:面上项目
靶向PARylation介导的DNA损伤修复途径在恶性肿瘤治疗中的作用与分子机制研究
- 批准号:82373145
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
基于密度泛函理论金原子簇放射性药物设计、制备及其在肺癌诊疗中的应用研究
- 批准号:82371997
- 批准年份:2023
- 资助金额:48.00 万元
- 项目类别:面上项目
BRPF1 m6A修饰异常通过重塑BCAT1超级增强子介导Setd2缺陷型肾癌支链氨基酸代谢成瘾的机制研究
- 批准号:82372724
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
基于影像代谢重塑可视化的延胡索酸水合酶缺陷型肾癌危险性分层模型的研究
- 批准号:82371912
- 批准年份:2023
- 资助金额:48.00 万元
- 项目类别:面上项目
DRAM1与VAMP8相互作用调控自噬融合以促进肺癌细胞血管外渗的分子机制研究
- 批准号:32000523
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
SAMMSON-CARF-p53信号轴调控黑色素瘤适应性耐药的机制研究
- 批准号:32000541
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
A Pilot Feasibility Study of an Intervention to Decrease Overtreatment of Low-risk Thyroid Cancer
减少低危甲状腺癌过度治疗的干预措施试点可行性研究
- 批准号:
10729147 - 财政年份:2023
- 资助金额:
$ 50万 - 项目类别:
Development of a risk assessment system using minimally invasive comprehensive preoperative genetic testing for thyroid cancer
甲状腺癌术前微创综合基因检测风险评估系统的开发
- 批准号:
22K07476 - 财政年份:2022
- 资助金额:
$ 50万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Use of a decision aid to resolve uncertainty about radioactive iodine treatment in patients with intermediate-risk thyroid cancer: the Radiance trial
使用决策辅助解决中危甲状腺癌患者放射性碘治疗的不确定性:Radiance 试验
- 批准号:
10523258 - 财政年份:2022
- 资助金额:
$ 50万 - 项目类别:
De-implementation of inappropriate thyroid ultrasound
取消不适当的甲状腺超声检查
- 批准号:
10665774 - 财政年份:2022
- 资助金额:
$ 50万 - 项目类别:
Development of a multi-analyte diagnostic assay to improve the risk stratification of indeterminate thyroid nodules
开发多分析物诊断测定法以改善不确定甲状腺结节的风险分层
- 批准号:
10545522 - 财政年份:2022
- 资助金额:
$ 50万 - 项目类别:
Radiosensitization of thyroid cancer by cancer cell specific reduction of gold ions
癌细胞特异性还原金离子对甲状腺癌的放射增敏作用
- 批准号:
10372483 - 财政年份:2022
- 资助金额:
$ 50万 - 项目类别:
Development of a multi-analyte diagnostic assay to improve the risk stratification of indeterminate thyroid nodules
开发多分析物诊断测定法以改善不确定甲状腺结节的风险分层
- 批准号:
10684875 - 财政年份:2022
- 资助金额:
$ 50万 - 项目类别:
Clinical Validation of Metabolic Markers Detected by Mass Spectrometry Imaging for Diagnosis of Thyroid Fine Needle Aspiration Biopsies
质谱成像检测代谢标志物诊断甲状腺细针抽吸活检的临床验证
- 批准号:
10598505 - 财政年份:2022
- 资助金额:
$ 50万 - 项目类别:
Radiosensitization of thyroid cancer by cancer cell specific reduction of gold ions
癌细胞特异性还原金离子对甲状腺癌的放射增敏作用
- 批准号:
10569671 - 财政年份:2022
- 资助金额:
$ 50万 - 项目类别: